Overview
Details
Chat
BioNTech SE's Q4 2021 Earnings Conference Call
Live streaming time: 30/03/2022 12:00
BioNTech SE Sponsored ADR was established in 2008 with a focus on the development of molecular immunotherapies and biopharmaceutical-based diagnostics. The company combines pioneering research with cutting-edge technology to develop groundbreaking therapies for cancer and other areas. As the company continues to demonstrate the value of this approach in clinical settings, it builds partnerships, manufacturing capabilities, and teams to provide personalized treatment to patients worldwide. Beginning with its roots in Mainz, Germany, the company has been committed to becoming a global leader in personalized cancer therapy biotechnology.
Live Assistant
Risk and Disclaimer Statement:
The content on this page reflects the personal opinion of the author and is intended solely as general information for your reference. It shall not be construed as advice or a basis for any specific investment, business, or commercial decisions. The views expressed in the content do not represent any position of LongPort or any investment recommendations or endorsements related to LongPort. LongPort does not make any guarantee or commitment to the truthfulness, accuracy, or originality of the content. Investors should analyze the risks related to the investment based on their own circumstances and seek advice from a professional investment advisor when necessary.